|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 463.40 INR | -2.21% |
|
+7.08% | +5.00% |
| 05-23 | Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| 05-22 | Unichem Laboratories March-quarter consol profit 109.1 million rupees | RE |
| Market Cap | 20.68B 218M 191M 176M 164M 309M 315M 2.11B 819M 10.15B 817M 799M 35.33B | P/E 2024 |
-48.8x | P/E 2025 | 35.6x |
|---|---|---|---|---|---|
| Enterprise Value | 24.38B 256M 225M 207M 193M 364M 372M 2.49B 966M 11.97B 963M 942M 41.65B | EV / Sales 2024 |
2.07x | EV / Sales 2025 | 2.49x |
| Free-Float |
28.71% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.21% | ||
| 1 week | +7.08% | ||
| Current month | -0.22% | ||
| 1 month | +35.18% | ||
| 3 months | +54.75% | ||
| 6 months | +5.35% | ||
| Current year | +5.00% |
| 1 week | 427.3 |  | 487.15 |
| 1 month | 353.5 | | 515.55 |
| Current year | 280 | | 515.55 |
| 1 year | 280 | | 656.85 |
| 3 years | 280 | | 949.85 |
| 5 years | 197.5 | | 949.85 |
| 10 years | 75.1 | | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 08/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 22/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 10/08/2023 |
| Director/Board Member | 57 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.21% | +7.08% | -22.23% | +23.82% | 351M | |
| +1.48% | +7.62% | +55.73% | +163.01% | 1,063B | |
| +2.52% | +6.30% | +67.33% | +59.35% | 611B | |
| +2.80% | +6.18% | +35.34% | +91.22% | 444B | |
| +4.17% | -0.96% | +26.12% | +20.22% | 324B | |
| +4.94% | +3.39% | +39.92% | +40.14% | 285B | |
| +2.42% | +1.60% | +30.06% | +44.59% | 283B | |
| +2.47% | +5.18% | -24.80% | -38.67% | 219B | |
| +3.05% | +5.37% | +25.24% | +65.22% | 195B | |
| +3.41% | +5.16% | +16.79% | +69.76% | 156B | |
| Average | +2.58% | +3.49% | +24.95% | +53.87% | 358.1B | |
| Weighted average by Cap. | +2.71% | +4.16% | +40.93% | +82.60% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.05B 179M 157M 145M 135M 255M 260M 1.74B 675M 8.37B 673M 659M 29.12B | 21.11B 222M 195M 179M 167M 315M 322M 2.16B 836M 10.36B 834M 816M 36.06B |
| Net income | -705M -7.41M -6.51M -5.99M -5.58M -10.53M -10.74M -72.05M -27.92M -346M -27.83M -27.23M -1.2B | 1.38B 14.46M 12.7M 11.69M 10.89M 20.54M 20.96M 141M 54.48M 675M 54.31M 53.14M 2.35B |
| Net Debt | 953M 10.02M 8.8M 8.1M 7.55M 14.23M 14.52M 97.4M 37.74M 468M 37.62M 36.81M 1.63B | 3.7B 38.94M 34.19M 31.47M 29.32M 55.3M 56.42M 378M 147M 1.82B 146M 143M 6.32B |
Employees
3,142
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | ₹463.40 | -2.21% | 3,956 |
| 01/07/26 | ₹473.85 | +2.03% | 16,644 |
| 30/06/26 | ₹464.40 | +2.43% | 10,673 |
| 29/06/26 | ₹453.40 | +4.86% | 20,985 |
| 25/06/26 | ₹432.40 | -0.08% | 4,025 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
